期刊
SEMINARS IN IMMUNOPATHOLOGY
卷 31, 期 4, 页码 455-465出版社
SPRINGER HEIDELBERG
DOI: 10.1007/s00281-009-0182-3
关键词
Multiple sclerosis; Inflammation; Microglia; Neurodegeneration; Mitochondria; Age; Progressive MS; Relapsing/remitting MS
Multiple sclerosis (MS) is a chronic inflammatory, demyelinating disease of the central nervous system, which starts in the majority of patients with a relapsing/remitting MS (RRMS) course , which after several years of disease duration converts into a progressive disease. Since anti-inflammatory therapies and immune modulation exert a beneficial effect at the relapsing/remitting stage of the disease, but not in the progressive stage, the question was raised whether inflammation drives tissue damage in progressive MS at all. We show here that also in progressive MS, inflammation is the driving force for brain injury and that the discrepancy between inflammation-driven tissue injury and response to immunomodulatory therapies can be explained by different pathomechanisms acting in RRMS and progressive MS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据